Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123741264 | 12374126 | 4 | F | 20160907 | 20160517 | 20160913 | EXP | JP-GLENMARK PHARMACEUTICALS INC, USA.-2016GMK022923 | GLENMARK | YOSHIMURA Y, SAKAMOTO Y, AMANO Y, TACHIKAWA N.. CASE REPORT: CLINDAMYCIN WITH PRIMAQUINE THERAPY FOR SEVERE PNEUMOCYSTIS PNEUMONIA. KANSENSHOGAKU ZASSHI.. 2015;89(5):601-605 | 60.00 | YR | F | Y | 34.56000 | KG | 20160913 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123741264 | 12374126 | 1 | PS | SULFAMETHOXAZOLE AND TRIMETHOPRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Intravenous (not otherwise specified) | UNK | Y | 0 | |||||||||
| 123741264 | 12374126 | 2 | SS | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | Intravenous (not otherwise specified) | 40 MG, QD | Y | 0 | 40 | MG | |||||||
| 123741264 | 12374126 | 3 | SS | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | Unknown | 60 MG, QD | Y | 0 | 60 | MG | |||||||
| 123741264 | 12374126 | 4 | SS | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | Unknown | 40 MG, UNK (EVERY 3-4 DAYS) | Y | 0 | 40 | MG | |||||||
| 123741264 | 12374126 | 5 | SS | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | Unknown | EVERY 3-4 DAYS20 MG, | Y | 0 | 20 | MG | |||||||
| 123741264 | 12374126 | 6 | SS | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | Unknown | 10 MG, EVERY 3-4 DAYS | Y | 0 | 10 | MG | |||||||
| 123741264 | 12374126 | 7 | C | CEFEPIME | CEFEPIME HYDROCHLORIDE | 1 | 3 G, QD | 0 | 3 | G | |||||||||
| 123741264 | 12374126 | 8 | C | CEFEPIME | CEFEPIME HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 123741264 | 12374126 | 9 | C | PIPERACILLIN/TAZOBACTAM | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Intravenous (not otherwise specified) | UNK | 0 | ||||||||||
| 123741264 | 12374126 | 10 | C | VANCOMYCIN | VANCOMYCIN | 1 | Intravenous (not otherwise specified) | UNK | 0 | ||||||||||
| 123741264 | 12374126 | 11 | C | LEVOFLOXACINE /01278901/ | LEVOFLOXACIN | 1 | Intravenous (not otherwise specified) | UNK | 0 | ||||||||||
| 123741264 | 12374126 | 12 | C | MICAFUNGIN | MICAFUNGIN | 1 | Intravenous (not otherwise specified) | UNK | 0 | ||||||||||
| 123741264 | 12374126 | 13 | C | HYDROCORTISONE /00028602/ | HYDROCORTISONE | 1 | Intravenous (not otherwise specified) | 200 MG, | 0 | 200 | MG | ||||||||
| 123741264 | 12374126 | 14 | C | HYDROCORTISONE /00028602/ | HYDROCORTISONE | 1 | Intravenous (not otherwise specified) | 20 MG, UNK | 0 | 20 | MG | ||||||||
| 123741264 | 12374126 | 15 | C | HYDROCORTISONE /00028602/ | HYDROCORTISONE | 1 | Intravenous (not otherwise specified) | 100 MG, UNK | 0 | 100 | MG | ||||||||
| 123741264 | 12374126 | 16 | C | CLINDAMYCIN | CLINDAMYCINCLINDAMYCIN PHOSPHATE | 1 | Unknown | UNK | 0 | ||||||||||
| 123741264 | 12374126 | 17 | C | PRIMAQUINE | PRIMAQUINE PHOSPHATE | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123741264 | 12374126 | 1 | Pneumocystis jirovecii pneumonia |
| 123741264 | 12374126 | 2 | Colitis ulcerative |
| 123741264 | 12374126 | 7 | Wound infection |
| 123741264 | 12374126 | 8 | Pyrexia |
| 123741264 | 12374126 | 9 | Acute respiratory distress syndrome |
| 123741264 | 12374126 | 10 | Acute respiratory distress syndrome |
| 123741264 | 12374126 | 11 | Acute respiratory distress syndrome |
| 123741264 | 12374126 | 12 | Acute respiratory distress syndrome |
| 123741264 | 12374126 | 13 | Product used for unknown indication |
| 123741264 | 12374126 | 16 | Product used for unknown indication |
| 123741264 | 12374126 | 17 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123741264 | 12374126 | OT |
| 123741264 | 12374126 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123741264 | 12374126 | Adverse event | |
| 123741264 | 12374126 | Hepatic enzyme increased | |
| 123741264 | 12374126 | Pneumonia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |